Koyfin Home > Directory > Health Care > Acadia Pharmaceutica > Total Revenue

Acadia Pharmaceutica Total Revenue Chart (ACAD)

Acadia Pharmaceutica annual/quarterly Total Revenue from 2010 to 2020. Revenue is the money that a business receives from its normal business activities, usually from the sale of goods and services to customers.
  • Acadia Pharmaceutica Total Revenue for the quarter ending June 06, 2020 was $110m a 14.09% increase of 16m year over year
  • Acadia Pharmaceutica Total Revenue for the last 12 months ending June 06, 2020 was $393m a 23.60% increase of 93m year over year
  • Acadia Pharmaceutica Annual Total Revenue for 2019 was $339m a 34.00% increase of 115m from 2018
  • Acadia Pharmaceutica Annual Total Revenue for 2018 was $224m a 44.19% increase of 99m from 2017
  • Acadia Pharmaceutica Annual Total Revenue for 2017 was $125m a 86.12% increase of 108m from 2016
Other Income Statement Metrics:
  • Acadia Pharmaceutica EBITDA for the quarter ending December 12, 2018 was $-67m a 18.74% decrease of -12m year over year
  • Acadia Pharmaceutica Net Income for the quarter ending December 12, 2018 was $-65m a 17.10% decrease of -11m year over year
View Chart On Koyfin

Quarterly ACAD Total Revenue Data

06/2020$110m
03/2020$90m
12/2019$98m
09/2019$95m
06/2019$83m
03/2019$63m
12/2018$60m
09/2018$58m
06/2018$57m
03/2018$49m

Annual ACAD Total Revenue Data

2019$339m
2018$224m
2017$125m
2016$17m
2015$0m
2014$0m
2013$1m
2012$5m
2011$2m
2010$42m